Erratum: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

Correction to: British Journal of Cancer (2017) 116, 1402–1407. doi:10.1038/bjc.2017.119; published online 25 April 2017 The authors would like to add Dr Rose Parkinson to the author list. She now appears in the author list, and her affiliation is also provided, above. The authors would like to chan...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2018-01, Vol.118 (2), p.e2-e2
Hauptverfasser:	Shroff, Rachna T, Yarchoan, Mark, O'Connor, Ashley, Gallagher, Denise, Zahurak, Marianna L, Rosner, Gary, Ohaji, Chimela, Sartorius-Mergenthaler, Susan, Parkinson, Rose, Subbiah, Vivek, Zinner, Ralph, Azad, Nilofer S
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical and Life Sciences Biomedicine Cancer Research corrigendum Drug Resistance Epidemiology Erratum Molecular Medicine Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Correction to: British Journal of Cancer (2017) 116, 1402–1407. doi:10.1038/bjc.2017.119; published online 25 April 2017 The authors would like to add Dr Rose Parkinson to the author list. She now appears in the author list, and her affiliation is also provided, above. The authors would like to change the acknowledgments to the following:
ISSN:	0007-0920 1532-1827
DOI:	10.1038/bjc.2017.418